Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review

doi:10.5306/wjco.v13.i11.929

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3313)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

151

WORD

HTML

1505

Figures (1-2)

129

Tables (1-3)

159

Sum=1980

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

202

Download

455

Sum=657

Publishing Process of This Article

Item

Count

Browse

248

Download

428

Sum=676

Nov 24, 2022 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Oncol. Nov 24, 2022; 13(11): 929-942
Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.929

Open in New Tab Full Size Figure Download Figure

Figure 1 Prisma flow diagram of study selection.

Open in New Tab Full Size Figure Download Figure

Figure 2 Phylogenetic tree showing family and species of gut microbiome abundant in responders and non-responders to immune-checkpoint blockade therapy in all included studies. Gut microbiome species highlighted in red: Abundant in non-responders to immune-checkpoint blockade therapy; blue: Abundant in responders to immune-checkpoint blockade therapy; purple: Abundant in both responders and non-responders.

Citation: Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. World J Clin Oncol 2022; 13(11): 929-942
URL: https://www.wjgnet.com/2218-4333/full/v13/i11/929.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i11.929